<DOC>
	<DOCNO>NCT01707160</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate pharmacokinetics pharmacodynamics insulin X14 30/70 PreMix compare human insulin 30/70 PreMix healthy volunteer .</brief_summary>
	<brief_title>Pharmacokinetics Pharmacodynamics Biphasic Insulin Aspart 30 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin aspart , insulin aspart protamine drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Nonsmokers BMI ( body mass index ) maximum 27 kg/m^2 HbA1c ( glycosylated haemoglobin A1c ) : 3.46.1 % FBG ( fast blood glucose ) maximum 6.0 mmol/L</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>